Healthy people test new Alzheimer's drug to see how it works
NCT ID NCT06955741
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single dose of an experimental drug called BMS-986446 in 46 healthy adults. The goal was to measure how the drug moves through the body and how well it is tolerated when given as a shot under the skin. The results will help design future studies for people with Alzheimer's disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution - 0001
Anaheim, California, 92801, United States
-
Local Institution - 10000
Anaheim, California, 92801, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?